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doi:10.1016/j.ejvs.2011.04.020Abstract Objective: To determine the utility of duplex guided angioplasty for hemodialysis
access maturation and maintenance.
Design/Materials/Methods: Between January 2008 and June 2009, 223 office-based duplex-
guided hemodialysis access angioplasty procedures were performed in 125 patients. Two
hundred eight of the accesses were autogenous. The most common indication for intervention
was maturation failure (104 cases). Other indications included pulsatility, low access flow,
decreased flow and infiltration. Procedures were performed in the office using topical and
local anesthesia. Volume flow (VF) was recorded prior to introducer insertion (baseline) and
post intervention.
Results: Technical success was achieved in 219 cases (98.2%). Minor complications occurred in
21 cases (9.4%). Immature autogenous AV accesses had a median baseline VF of 210 mL/min.
Median final VF for these autogenous AV accesses was 485 mL/min. The VF increased by 131%.
Dysfunctional autogenous AV accesses and nonautogenous AV accesses had a median baseline
VF of 472 mL/min. Median final VF was 950 mL/min. The VF increased by 101%.
Conclusions: Duplex guided dialysis access angioplasty can be performed safely and effectively
in the office setting. It offers the advantage of treating the patient without radiation or
contrast as well as the assessment of the hemodynamic effects of intervention.
ª 2011 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.045 Park Avenue, New York, NY 10028, USA. Tel.: þ1 212 362 3470; fax: þ1 212 362 3496.
.com (D. Fox).
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Table 1 Patient characteristics.
Variable n
Interventions, No. 223
Patient, No. 125
Sex M/F, No. 68/57
Age, years 65.5 (29e89)
Access location
Forearm 67%
Arm 33%
Access type
Autogenous AV access 208
Nonautogenous AV access 15
Table 2 Indications for intervention.a
Variable n
Maturation failure 104
Pulsatility 29
Low access flow 28
Decreased access flow 23
Infiltration 13
Aneurysmal degeneration 11
Bleeding 9
Pseudoaneurysmal degeneration 6
Elevated venous pressures 5
Difficult cannulation 3
Pain 3
Ulceration 1
Recirculation 1
Swelling 1
Decreased arterial pressures 1
a More than one indication for intervention was often present
in an individual patient.
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Endovascular intervention for immature or malfunctioning
AV access has traditionally been performed using tech-
niques dependent upon fluoroscopic guidance. These
techniques expose the patient to the risks associated with
exposure to iodinated contrast and ionizing radiation.1e3
Sedation has also been routinely administered during
these procedures. Sedation also carries risks, particularly in
patients with renal failure as a consequence of enhanced
drug sensitivity, co-morbidities and concurrent medication
use.4 Additional drawbacks of the traditional approach
include exposure of personnel to radiation and the high
costs associated with fluoroscopic imaging hardware,
contrast and personnel required for the monitoring of
patients who have received IV sedation.5e7
To avoid these hazards, techniques have been developed
for hemodialysis access intervention that utilize duplex
ultrasound guidance.1,6e17 Although first reported by Wit-
tenberg in 1996,17 there has been a recent increase in
reports of ultrasound guided dialysis intervention. The
Maimonides group has published several favorable reports
of Duplex-guided hemodialysis access intervention in both
failing and non-maturing accesses.1,6,11,12 They have also
shown that these procedures can be safely and successfully
performed in the office setting.1 Furthermore, ultrasound
guided access intervention has been shown to offer
economic advantages for the medical system as well as the
practicioner.1,18 As mentioned previously, the clinical
advantages of duplex-guided intervention include avoid-
ance of the risks of iodinated contrast, ionizing radiation
and sedation. There are also significant technical advan-
tages including the ability to directly visualize puncture
sites, stenoses, thrombus, spasm and extravascular flow in
real-time.16
By using duplex one is also able to directly measure the
diameter of treated vessels, which facilitates the accurate
sizing of balloons and stents. The ability to measure
diameter, flow velocity and volume flow also provides the
opportunity to objectively and quantitatively assess the
need for and the results of intervention.19
Further advantages include a strong patient and physi-
cian preference for the convenience and efficiency of the
office environment as compared to the hospital. In light of
the favorable experience reported, we began performing
office-based duplex-guided access intervention in January
of 2008. In this report we describe these techniques and
present our early results.
Materials and Methods
Demographics
During the 17-month period of January 2008 through June
2009, 223 consecutive office-based duplex-guided hemodi-
alysis access interventions were performed in 125 patients
by a single vascular surgeon (DF) in a practice with a strong
focus on the creation and maintenance on hemodialysis
access (Table 1). There were 68 males and 57 females.
Mean age was 65.5 years; range 29e89 years. The anatomic
distribution of the treated accesses was the forearm in 67%and the upper arm in 33%. The majority of treated accesses
were autogenous AV accesses (AAVA) (208). Fifteen were
nonautogenous (NAAVA).
Indications
The most common indication for intervention was matura-
tion failure, which occurred in 104 cases (Table 2). A
diagnosis of maturation failure was made using both clinical
and duplex criteria. Duplex criteria include AAVA diameter
less than 6 mm and access flow less than 600 mL/min.
Clinical criteria included the inability to achieve prescribed
dialysis flow rates and difficulty with cannulation. Other
indications included pulsatility (29), low access flow (28),
decreased flow (23), infiltration (13), aneurysmal degen-
eration (11), bleeding (9), pseudoaneurysmal degeneration
(6), elevated venous pressures (5), difficult cannulation (3),
pain (3), ulceration (1), decreased clearance (1), swelling
(1) and decreased arterial pressures (1). More than one
indication for intervention was often present in an indi-
vidual patient. Hemodynamically significant stenoses were
identified and characterized by the presence of B-mode
diameter reduction, color bruit and peak systolic velocity
elevation >2.1,7,20e22
Figure 1 Procedure room setup for duplex guided AV access
intervention. The patient’s right arm is seen in the middle of
the figure. The duplex scanner is in the background.
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Patients were not considered appropriate candidates for
office-based duplex-guided intervention in a small number
of defined clinical circumstances. When such a circum-
stance did occur, the patient underwent conventional
treatment in a hospital setting. Exclusion criteria included
both anatomic and non-anatomic characteristics.
An important anatomic exclusion criterion was the
suspicion of clinically relevant central vein pathology.
Central vein pathology was suspected in patients with
a clinical presentation of arm swelling and/or a history of
clinically significant central vein pathology or abnormal
duplex findings. Duplex findings suggestive of central vein
abnormalities include those directly visualized or indirectly
inferred by duplex waveform analysis. A finding of a non-
pulsatile central vein waveform ipsilateral to the access
suggested a hemodynamically significant stenosis or occlu-
sion central to the area of insonation.23e27 This was an
uncommon occurrence in our series perhaps as a result of our
practice to routinely assess the central veins in patients
perceived to be at risk for occult central vein pathology prior
to access creation. The low incidence of central vein
pathology in our series is consistent with the observations of
Kanterman who found that in a large series of vascular graft
access malfunction, 93% of stenotic lesions are located
between the arterial anastomosis and the axillary vein.28
Non-anatomic characteristics of patients excluded from
in office treatment include those with a strong preference
for treatment in a hospital setting or those requiring
sedation. Again, these were uncommon events in our
series.
Interventions
The types of intervention performed under duplex guidance
included maturation angioplasty and maintenance angio-
plasty. Maturation angioplasty was performed in 115 cases.
Maintenance angioplasty was performed in 108 cases.
Technique
All procedures were performed in a freestanding office
procedure room. Room setup for the procedure is illus-
trated in Figs. 1 and 2. Both the surgeon and vascular
technologist scrubbed for the procedure. A non-scrubbed
circulator was present. Occasionally an assistant scrubbed
in as well. Patients were instructed to apply a topical
anesthetic cream (2.5% lidocaine/2.5% prilocaine) with an
occlusive dressing over the access site two to 3 h prior to
the procedure. After informed consent was obtained the
extremity was scrubbed with chlorhexidine and draped in
the usual sterile manner. Local infiltration at introducer
and angioplasty sites was performed with an equal parts
mixture of 2% Lidocaine and 1% Bupivacaine. A small
quantity of sodium bicarbonate solution was added to the
mixture to reduce acidity. No intravenous sedation was
administered.
Image guidance for the procedure was obtained using
the Zonare z.one ultra Ultrasound System (Zonare Medical
Systems, San Francisco, California, USA). Both the keyboardand probe (L10-5 Linear array transducer) were covered
with sterile plastic drapes (Civco Medical Solutions, Kalona,
Iowa, USA). After baseline measurements were recorded
(volume flow, vessel diameter and flow velocity), access
was obtained using a 5 French micropuncture set (Merit
Medical Systems, South Jordan, Utah, USA). Both antegrade
and retrograde approaches were utilized depending upon
the anatomical location of the stenosis.
Angioplasty balloon size was determined by measuring
the vessel diameter adjacent to the stenotic segment and
oversizing by 1e1.5 mm. Once the angioplasty balloon had
been selected, the micropuncture catheter was exchanged
for an introducer sheath and 3000 units of heparin were
administered through the sheath. Additional 1000 unit doses
were administered after 45 min when necessary. 4 French
through 7 French diameter introducer sheaths were used
(Terumo Medical Corporation, Somerset, New Jersey, USA).
A guidewire (.035 or .018 mm) was then advanced
through the stenotic area and positioned beyond the
stenosis in such a manner as to maintain good endovascular
control of the area to be treated. All these maneuvers were
performed under direct, continuous duplex ultrasound
guidance so as to avoid inadvertent wire passage into
tributaries or vessel wall trauma. At this point, ultrasound
guided local anesthetic infiltration at the angioplasty site
was performed. Care was taken to administer the peri-
venous anesthetic prior to balloon insertion so as to avoid
the possibility of angioplasty balloon puncture with the
anesthetic needle.
Angioplasty was then performed with either low profile,
standard-pressure, high-pressure or cutting balloons as
indicated by stenosis characteristics and response to
angioplasty. Angioplasty balloon diameters ranged between
2 mm and 12 mm. The diameter of balloon most commonly
used was 6 mm (Table 3). The balloons used in this study
were Ultraverse, Vaccess and Conquest (CR Bard, Murray
Hill, New Jersey, USA). Cutting balloons (Boston Scientific,
Natick, Massachusetts, USA) were required for resistant
stenoses in 3 cases. Once full profile was achieved, the
inflation pressure was typically brought several atmospheres
higher and then maintained for a period of approximately
Figure 2 Composite duplex scan of a non-maturing autogenous high origin radial artery-basilic vein transposition. The arrow
indicates the inflow radial artery. There is a long area of arterial end stenosis which measures .15 cm in diameter.
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Figs. 3e5.
Post angioplasty duplex assessment was then performed.
This included measurement of diameter; velocity and
volume flow as well as assessment for complications such as
rupture, thrombosis or spasm. After a final result had been
achieved, 4-0 polypropylene sutures were placed at the
introducer sites and the introducers were removed.
Partially occlusive pressure was held for approximately
3 min after which the access sites were interrogated for
hemostasis. An additional period of compression was per-
formed if necessary. Once hemostasis had been demon-
strated, final measurements of diameter, velocity and
volume flow were obtained. A dressing was then placed,
vital signs were checked and the patient was discharged.
Procedure duration averaged 55 min with a range of
15e169 min.
A determination of technical success was made at the
time of the procedure. This determination was made upon
consideration of a number of quantifiable factors such as
changes in vessel diameter, reduction in flow velocity ratio
to less than 2 and volume flow. The determination also took
into account subjective phenomenon such as vasospasm at
angioplasty and introducer sites which can transiently blunt
changes in the quantitative endpoints.
For the purpose of this study only volume flow
measurements are reported. Volume flow measurements
were made in a non-tortuous segment of the access that
demonstrated laminar color flow. Volume flow wasTable 3 Frequency of angioplasty balloon use.
Balloon diameter
(mm)
First balloon,
No.
Second balloon,
No.a
2 e 1
3 1 6
4 14 4
5 44 6
6 65 6
7 42 3
8 23 4
9 16 2
10 9 e
12 1 e
a When a second balloon was required.recorded prior to introducer insertion (baseline) and post
intervention. Final volume flow was also recorded post
introducer removal. An effort was made to record volume
flow in the same anatomic site to minimize measurement
variability related to anatomical factors.
Statistical analysis was performed using SigmaStat,
Version 3.5. The statistical significance of differences in
volume flow measurements pre and post intervention was
assessed using the Paired t-test. The data distribution
was first evaluated with the normality test and the data was
found to be non-parametric in all comparisons. Because of
this the Wilcoxon Signed Rank Test was applied and median
values were reported.ResultsTechnical success
Technical success was achieved in 219 cases (98.2%). Tech-
nical failure was experienced in 4 cases (1.79%). These fail-
ures occurred in 4 maintenance angioplasty cases. There
were no technical failures in thematuration series. Technical
failure was the result of an inability to cross an occluded
anastomosis or outflow segment in two cases. The causes of
technical failure in the two other cases were recoiling
stenosis and resistant stenosis. These were addressed with
surgical repair and cutting balloon respectively.
Stents were placed in 5 cases. Four of the stents were
covered, 1 stent was a bare metal stent. The most common
indication for stent placement was pseudoaneurysm
formation (2). Other indications for stent placement were
vein rupture (2) and elastic recoil (1). Arterial angioplasty
(in addition to venous or graft angioplasty) was performed
in 16 cases. Trans-radial access was not utilized in this
series.
Complications
Minor complications occurred in 17 cases (7.6%). There
were 2 major complications (.89%). Access-site related
complications included small introducer site hematomas in
2 cases and the formation of small introducer site pseu-
doaneurysms in 4 cases. These findings were visualized on
ultrasound but in general were not otherwise clinically
apparent. When visualized, a brief period of manual
Figure 3 Baseline duplex showing mosaic color bruit and high flow velocity (842 cm/s) with aliasing.
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access-site related complications was achieved in all cases.
Intra-luminal thrombus development was seen in 8
cases. This was seen at both angioplasty and introducer
sites. When the thrombus was occlusive or appeared to
present a potentially significant obstruction to flow, addi-
tional heparin was given and maceration thrombectomy
was performed. Thrombectomy was successful in all cases.Figure 4 B-mode images depicting angioplasty balloon inflation
maximal stenosis. Top right image shows full profile at the stenosis
guidewire. Bottom image taken with balloon at full profile. Arrow
bright line extending across the entire image represents a BentsenAngioplasty site rupture was seen in 3 cases. Initial
treatment included balloon re-inflation and external
compression. Covered stent placement (Fluency, CR Bard)
was performed in 2 of the cases of rupture. Control of
rupture was achieved in all cases. Small angioplasty site
pseudoaneurysms developed in 2 cases. One was treated
with compression. The second was observed and remained
stable.. Top left image shows a waist in the balloon at the site of
site. Arrow points to the transition point between balloon and
s indicate the central and peripheral ends of the balloon. The
wire.
Figure 5 Duplex showing markedly increased volume flow following angioplasty of arterial end stenosis. Volume flow increased
from 379 to 873 mL/min.
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Volume flow (VF) was measured pre and post intervention.
A complete set of both pre and post intervention VF
measurements were available for analysis in 205 of the 223
procedures (92%). Average and median VF for each type of
intervention were calculated and pre and post intervention
volume flows were compared. VF was found to increase
significantly across all treatment categories (Table 4). As
the data distribution was found to be non-parametric, the
median VF rather than the average VF was used for deter-
mination of statistical significance.
For all interventions combined, the median baseline VF
was 340 mL/min. The median final VF was 663 mL/min. The
VF increased by 95% post intervention (P < 0.001).
The immature AAVA’s undergoing maturation angioplasty
had a median baseline VF of 210 mL/min. Median final VF
for these AAVA’s was 485 mL/min. The VF increased by 131%
after maturation angioplasty (P < 0.001).
Dysfunctional AAVA’s and NAAVA’s undergoing mainte-
nance angioplasty had a median baseline VF of 472 mL/min.
Median final VF was 950 mL/min. The VF increased by 101%
after maintenance angioplasty (P < 0.001).
Looking exclusively at the technically successful main-
tenance procedures, the median baseline VF was 451 mL/
min. Median final VF increased to 955 mL/min. The VF
increased by 84% post intervention (P < 0.001).Discussion
Our study clearly demonstrates that office-based duplex-
guided intervention is a safe and effective treatment for
immature and failing AV access. The principal measure of
therapeutic success was a significant increase in duplex
derived flow volume.Duplex derived access volume flow (DAVQ) has been
reported by Ascher to be a good predictor of clinical
success following endovascular repair of failing or imma-
ture access.29 He found that DAVQ for functioning AAVA’s
averaged 1199 mL/min. The DAVQ in AAVA’s that underwent
intervention and went on to become functional for dialysis
for at least 6 months was at least 867 mL/min. In our series,
the mean and median final volume flow for all interventions
was 820 and 663 mL/min. This is within range of the level
reported by Ascher so it is reasonable to infer that the
clinical outcomes in our series would be comparable.
Looking specifically at the accesses in our series that
underwent maintenance angioplasty, the mean and median
final VF were 1146 and 950 mL/min. This compares favor-
ably to the number reported by Ascher (1199 mL/min) so it
is reasonable to infer that the clinical outcomes of our
maintenance procedures would be excellent as well.
At first glance, the results of the maturation cases
appear not be as favorable as those of maintenance cases.
The mean and median final VF for the maturation
cases were 522 and 485 mL/min. While these indicate
a substantial increase in VF from baseline (93 and 131%),
these values are below the threshold of 867 mL/min
reported by Ascher. It is important to remember, however,
that the final VF for maturation cases in our series reflects
AAVA’s that were in various stages of maturation and is not
the final volume flow achieved after a complete series of
maturation angioplasty sessions for each AAVA. It therefore
likely that these aggregate numbers do not reflect values
that would be seen following a complete series of matu-
ration. It would be instructive to perform a separate anal-
ysis of the patients that had undergone a complete series of
maturation.
When comparing the results of our VF data to those of
other studies, it is important to note that volume flow
measurements obtained immediately after angioplasty and
Table 4 Volume flow measurements (VF).
Procedure type n Mean SDa Range Median 25% IQRb 75% IQR Pc
Maintenance þ maturation (All cases)
VF Pre (mL/min) 205 447 421 12e3265 340 168 556
VF Post (mL/min) 205 820 600 116e4475 663 444 1001
% Increase in VF 84% 95% <.001
Maintenance PTA (All cases)
VF Pre (mL/min) 98 639 506 110e3265 472 300 806
VF Post (mL/min) 98 1146 684 200e4475 950 721 1404
% Increase in VF 79% 101% <.001
Maintenance PTA (Successful cases)
VF Pre (mL/min) 94 616 437 110e2537 451 300 806
VF Post (mL/min) 94 1143 652 286e4475 955 727 1404
% Increase in VF 85% 112% <.001
Maturation PTA (All)
VF Pre (mL/min) 107 271 201 12e1030 210 108 397
VF Post (mL/min) 107 522 272 116e1410 485 292 658
% Increase in VF 93% 131% <.001
a SD, Standard deviation.
b IQR, Inter-quartile ratio.
c Wilcoxon signed rank test.
Duplex Guided Dialysis Access Interventions can be Performed Safely in the Office Setting 839introducer removal (as reported in this series) will display
a tendency to underestimate the effectiveness of angio-
plasty. This is related to the obstructive effects of intro-
ducer sheaths in small diameter, immature AAVA’s and
venospasm induced by introducer sheath removal. The
DAVQ measurements in the Maimonides series were made
within 2 weeks of the procedure. Presumably any
procedure-induced vasospasm would have completely
abated by the time these measurements were taken.Table 5 Clinical reports of duplex-guided AV access interventio
Year Author Location na Technical
success
VFb Pre PTA
(mL/min)
VF
(mL
2010 Fox New York 223 219/223 340
(12e3265)
663
(11
2009 Ascher New York 32 32/32 350  180 933
2009 Wang Philadelphia Case
report
1/1 e e
2007 Ascher New York 11 11/11 614  339 110
2007 Marks New York 10 10/10 658  324 115
2007 Kim Daejeon,
Korea
10 10/10 167
(80e259)
394
(12
2000 Bacchini Lecco, Italy 12 12/12 468  153 820
1996 Wittenberg Wurzburg,
Germany
39 38/39 361  83.5 719
a n, Number of interventions.
b VF, Volume flow.
c When reported.In immature AAVA’s the size of the introducer is often
large relative to the size of the access so that the intro-
ducer itself becomes a significant obstruction to flow. This
is an obvious point to the experienced interventionalist. It
becomes even more readily apparent when these rela-
tionships are visualized in real time with ultrasound.
In the immediate post introducer removal state there is
often spasm visualized at the introducer site. This is more
often the case with retrograde introducers placed in then.
Post PTA
/min)
P % Increase
in VFc
Clinical endpoint
6e4475)
<.001 95% e
 332 <.0001 e 1, 3 and 6-month primary
cumulative stenosis-free
patency rates: 96% 76% &
53%
e e e
3  416 <.01 118 
100%
100% 3-month stenosis-free
patency
4  402 < .01 107 
97%
100% 3-month stenosis-free
patency
0e586)
e e One or more successful
hemodialysis sessions after
treatment
 281 <.001 e 100% patent at one month
 189 e e e
840 D. Fox et al.venous or outflow side of an AAVA. Conversely, the ante-
grade/arterial end introducers are less often associated
with spasm, presumably related to higher pressures in this
area. When we have observed these accesses for brief
periods of time after introducer removal (less than an hour)
we have consistently observed a decrease in spasm and
a concomitant increase in volume flow.
Ultrasound-guided dialysis access intervention is not
a new concept. It was first reported in 1991 by Cluley in
a canine model of femoral arteriovenous access.8 The first
clinical report was by Wittenberg in 1996.17 Subsequently,
several other centers have published retrospective series
and case reports (Table 5).1e7,10,11,16,17 Our experience is
the largest reported to date. Technical success overall
appears to be excellent and is consistent across the
reported series. The principle technical endpoint reported
is an increase in volume flow, which was reported in all
series. The most robust clinical endpoint analysis is from
Ascher who reported 1, 3 and 6-month primary cumulative
stenosis-free patency rates of 96, 76 and 53% respec-
tively.1 A limitation of their life-table analysis is that they
did not distinguish mature from immature access. The
majority of the angioplasties were performed on non-
maturing AAVA’s (27/32). This likely accounts for the low
6-month primary patency as a number of these AAVA’s
would have required repeat intervention to become func-
tional. We saw a similar relative efficacy in our study as
the volume flow following intervention in mature mal-
functioning access was more pronounced than that seen
after angioplasty of immature AAVA’s. It is suggested that
future studies look at mature and immature AAVA’s sepa-
rately in order to obtain a more accurate picture of
technical and clinical efficacy in each of these rather
different clinical circumstances.
Given the demonstrated benefits of ultrasound-guided
access intervention, broader application is inevitable. Such
applications include thrombectomy procedures, procedures
utilizing trans-arterial access and treatment of inflow
arterial stenosis.9,14,15 We have had a small but developing
experience with these interventions and anticipate that
they will be the focus of future reports.
A deficiency of our study is the absence of an analysis of
additional technical endpoints such as a quantitative
change in diameter, flow velocity and a clinical endpoint,
such as functional patency. A further limitation of our study
is the absences of an analysis of the distribution of the
anatomical sites of treated stenoses. An analysis of such
factors was beyond the scale of this report but would
ideally be included in future studies.Conclusion
Duplex-guided dialysis access intervention for maintenance
and maturation can be performed safely and effectively in
the office setting and is tolerated well by most patients. It
offers the advantage of treating the patient without radi-
ation or contrast. It also allows for accurate sizing of
balloons and stents and assessment of the hemodynamic
effects of intervention. It is suggested that this technique
be considered as an important addition to the therapeutic
armamentarium.Funding
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